GlassScriptPhysician profile
Emily B Maas
NPI 1578721007
$12,425.50
in general payments reported to CMS, 2019-2025
12 companies · $9,194 in 2025
The $9,194 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.99 · 2021: $84.77 · 2022: $111 · 2023: $144 · 2024: $2,839 · 2025: $9,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,200 · Education: $4,500 · Travel and Lodging: $788 · Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,200.00 |
| Education | $4,500.00 |
| Travel and Lodging | $787.96 |
| Food and Beverage | $689.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $6,200.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $5,512.75 | 2025 | |
| Exeltis, USA INC. | $209.37 | 2020-2025 | Slynd, Tyblume |
| Biogen, INC. | $132.66 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $112.49 | 2021-2025 | |
| Organon LLC | $90.02 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $68.41 | 2025 | |
| Agile Therapeutics, INC. | $29.10 | 2022 | |
| Pfizer INC. | $21.89 | 2023 | |
| Corcept Therapeutics | $19.45 | 2020 | |
| Coopersurgical, INC. | $16.81 | 2025 | |
| Janssen Pharmaceuticals, INC | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Maas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.